DeepMind spinout building an AI drug design engine (IsoDDE) to accelerate discovery across therapeutic areas.
| Date | Round | Amount |
|---|---|---|
| May 2026 | Series B Isomorphic Labs (London), the DeepMind spinout led by Demis Hassabis, closed a $2.1B Series B led by Thrive Capital, among the largest AI drug discovery rounds ever raised in Europe. | $2.1B |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.